Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HCAR2 | Q8TDS4 | 4/20 | 0.69 |
| ▸ | ATM | Q13315 | 1/20 | 0.66 |
| ▸ | MAPT | P10636 | 1/20 | 0.50 |
| ▸ | RAB9A | P51151 | 1/20 | 0.50 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.50 |
| ▸ | NAAA | Q02083 | 1/20 | 0.48 |
| ▸ | APP | P05067 | 4/20 | 0.48 |
| ▸ | TSHR | P16473 | 2/20 | 0.47 |
| ▸ | HPGD | P15428 | 1/20 | 0.47 |
| ▸ | PRKCA | P17252 | 2/20 | 0.47 |
| ▸ | HTT | P42858 | 2/20 | 0.46 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.46 |
| ▸ | EPHX1 | P07099 | 1/20 | 0.46 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL1361703 | 1.00 | HCAR2 (0.69) | HCAR2ATMMAPTRAB9ANPSR1 | |
| SCHEMBL394039 | 1.00 | HCAR2 (0.69) | HCAR2ATMMAPTRAB9ANPSR1 | |
| SCHEMBL394041 | 1.00 | HCAR2 (0.69) | HCAR2ATMMAPTRAB9ANPSR1 | |
| SCHEMBL5689031 | 1.00 | HCAR2 (0.69) | HCAR2ATMMAPTRAB9ANPSR1 | |
| SCHEMBL10859931 | 1.00 | HCAR2 (0.69) | HCAR2ATMMAPTRAB9ANPSR1 | |
| SCHEMBL10859921 | 1.00 | HCAR2 (0.69) | HCAR2ATMMAPTRAB9ANPSR1 | |
| Hexyl Fumarate SCHEMBL11599799 | 0.94 | HCAR2 (0.81) | HCAR2ATMMAPTRAB9ANPSR1 | |
| SCHEMBL6904516 | 0.94 | HCAR2 (0.81) | HCAR2ATMMAPTRAB9ANPSR1 | |
| Hexyl Fumarate SCHEMBL11599810 | 0.94 | HCAR2 (0.81) | HCAR2ATMMAPTRAB9ANPSR1 | |
| SCHEMBL27680539 | 0.94 | HCAR2 (0.81) | HCAR2ATMMAPTRAB9ANPSR1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-8067508-B2 | Compositions consisting of partially silyl-terminated polymers | HENKEL AG & CO. KGAA (DE) | 2011-11-29 | — | — | US | disclosed |
| US-20100160476-A1 | FLAME-RETARDANT ADDITIVES | HENKEL AG &CO. KGAA (DE) | 2010-06-24 | — | — | US | disclosed |
| US-20100081757-A1 | COMPOSITIONS CONSISTING OF PARTIALLY SILYL-TERMINATED POLYMERS | HENKEL AG & CO. KGAA (DE) | 2010-04-01 | — | — | US | disclosed |
| CN-1120557-A | Aqueous synthetic resin dispersion | HOECHST AG (DE) | 1996-04-17 | — | — | CN | disclosed |
| CN-1098120-A | Aqueous synthetic resin dispersion | HOECHST AG (DE) | 1995-02-01 | — | — | CN | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20100160476-A1 | FLAME-RETARDANT ADDITIVES | TP53RK, POLR1A, RER1 | HCAR2 3616/4885ATM 2324/4885MAPT 1522/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.